Back to dashboard
CommercialAdministrativeMedium impact

[Georgia] PY2027 Blue Value Individual Network HMO FAQ

Anthem BCBS·GA·Network
Effective date
Jan 1, 2027
We identified it
May 3, 2026
Days to comply
149 days

Summary

Anthem Blue Cross and Blue Shield is launching a new Blue Value Individual Network HMO product in select Georgia counties (rating areas 2 and 5) effective January 1, 2027, targeting cost-sensitive individuals earning 100-400% of Federal Poverty Level. Providers currently in Anthem's Medicaid network in these counties will receive opt-out letters and have 30 days to decline participation; Medicaid contract participation is required to join this new network, but participation in the new product is optional.

Action Required

Before Jan 1, 2027
By December 1, 2026: Providers in Anthem's Georgia Medicaid network located in rating areas 2 and 5 (Barrow, Oconee, Jenkins, Clarke, Oglethorpe, Lincoln, Elbert, Burke, McDuffie, Greene, Columbia, Richmond, Jackson, Emanuel, Taliaferro, Madison, Glascock, Warren, Morgan, Jefferson, Wilkes counties) must review the opt-out letter received from Anthem and decide whether to participate in the Blue Value Individual Network HMO. DEADLINE FOR OPT-OUT: Within 30 days of receiving the letter, submit opt-out request via email to AMGP_EXCG@anthem.com or call 833-823-0794 if declining participation. NOTE: Failure to opt out within 30 days will result in automatic enrollment in the new network, but providers may still terminate participation with 120-day written notice. Billing team should: (1) Confirm which providers in the practice are located in targeted counties; (2) Coordinate with providers to determine participation decision; (3) Track opt-out deadline and submission; (4) Update billing system credentialing records to reflect Blue Value Individual HMO network status by January 1, 2027; (5) Ensure claims processing workflow distinguishes between Medicaid and Blue Value individual plans to prevent billing errors. No existing Medicaid contracts will be affected by non-participation in the new product.